BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 24825746)

  • 21. Exploring novel targets of basal-like breast carcinoma by comparative gene profiling and mechanism analysis.
    Wu YM; Hu W; Wang Y; Wang N; Gao L; Chen ZZ; Zheng WQ
    Breast Cancer Res Treat; 2013 Aug; 141(1):23-32. PubMed ID: 23933801
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gene expression in 16q is associated with survival and differs between Sørlie breast cancer subtypes.
    Wennmalm K; Calza S; Ploner A; Hall P; Bjöhle J; Klaar S; Smeds J; Pawitan Y; Bergh J
    Genes Chromosomes Cancer; 2007 Jan; 46(1):87-97. PubMed ID: 17044045
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Breast carcinoma in pregnant women: assessment of clinicopathologic and immunohistochemical features.
    Middleton LP; Amin M; Gwyn K; Theriault R; Sahin A
    Cancer; 2003 Sep; 98(5):1055-60. PubMed ID: 12942575
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genomic aberrations in young and elderly  breast cancer patients.
    Azim HA; Nguyen B; Brohée S; Zoppoli G; Sotiriou C
    BMC Med; 2015 Oct; 13():266. PubMed ID: 26467651
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A Gene Regulatory Program in Human Breast Cancer.
    Li R; Campos J; Iida J
    Genetics; 2015 Dec; 201(4):1341-8. PubMed ID: 26510790
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Integrative analysis of somatic mutations and transcriptomic data to functionally stratify breast cancer patients.
    Zhang J; Abrams Z; Parvin JD; Huang K
    BMC Genomics; 2016 Aug; 17 Suppl 7(Suppl 7):513. PubMed ID: 27556157
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Correlated metabolomic, genomic, and histologic phenotypes in histologically normal breast tissue.
    Sun X; Stewart DA; Sandhu R; Kirk EL; Pathmasiri WW; McRitchie SL; Clark RF; Troester MA; Sumner SJ
    PLoS One; 2018; 13(4):e0193792. PubMed ID: 29668675
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A novel model to combine clinical and pathway-based transcriptomic information for the prognosis prediction of breast cancer.
    Huang S; Yee C; Ching T; Yu H; Garmire LX
    PLoS Comput Biol; 2014 Sep; 10(9):e1003851. PubMed ID: 25233347
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Biology of breast cancer in young women.
    Azim HA; Partridge AH
    Breast Cancer Res; 2014 Aug; 16(4):427. PubMed ID: 25436920
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Overexpressed somatic alleles are enriched in functional elements in Breast Cancer.
    Restrepo P; Movassagh M; Alomran N; Miller C; Li M; Trenkov C; Manchev Y; Bahl S; Warnken S; Spurr L; Apanasovich T; Crandall K; Edwards N; Horvath A
    Sci Rep; 2017 Aug; 7(1):8287. PubMed ID: 28811643
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Classical pathology and mutational load of breast cancer - integration of two worlds.
    Budczies J; Bockmayr M; Denkert C; Klauschen F; Lennerz JK; Györffy B; Dietel M; Loibl S; Weichert W; Stenzinger A
    J Pathol Clin Res; 2015 Oct; 1(4):225-38. PubMed ID: 27499907
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Genomic Profile of Pregnancy-Associated Breast Cancer: A Systematic Review.
    Korakiti AM; Moutafi M; Zografos E; Dimopoulos MA; Zagouri F
    Front Oncol; 2020; 10():1773. PubMed ID: 33014874
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Improving the power of gene set enrichment analyses.
    Roder J; Linstid B; Oliveira C
    BMC Bioinformatics; 2019 May; 20(1):257. PubMed ID: 31101008
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gene Expression Profiles in Cancers and Their Therapeutic Implications.
    Creighton CJ
    Cancer J; 2023 Jan-Feb 01; 29(1):9-14. PubMed ID: 36693152
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular Classification of Breast Cancer.
    Provenzano E; Ulaner GA; Chin SF
    PET Clin; 2018 Jul; 13(3):325-338. PubMed ID: 30100073
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Breast cancer diagnosed during pregnancy is associated with enrichment of non-silent mutations, mismatch repair deficiency signature and mucin mutations.
    Nguyen B; Venet D; Azim HA; Brown D; Desmedt C; Lambertini M; Majjaj S; Pruneri G; Peccatori F; Piccart M; Rothé F; Sotiriou C
    NPJ Breast Cancer; 2018; 4():23. PubMed ID: 30109263
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genomic perspective and cancer.
    Botstein D
    Cold Spring Harb Symp Quant Biol; 2003; 68():417-24. PubMed ID: 15338644
    [No Abstract]   [Full Text] [Related]  

  • 38. Integrated Multi-Omics Profiling of Young Breast Cancer Patients Reveals a Correlation between Galactose Metabolism Pathway and Poor Disease-Free Survival.
    Han X; Han B; Luo H; Ling H; Hu X
    Cancers (Basel); 2023 Sep; 15(18):. PubMed ID: 37760606
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genetics: Defining driver mutations in the genomic landscape of breast cancer.
    Hutchinson L
    Nat Rev Clin Oncol; 2016 May; 13(6):327. PubMed ID: 27199176
    [No Abstract]   [Full Text] [Related]  

  • 40. [Breast cancer and pregnancy, clinical and biological problems].
    HUGUENIN R; ROUJEAU J
    Sem Hop; 1949 Oct; 25(73):2985-91. PubMed ID: 15390856
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.